P Richette

Summary

Country: France

Publications

  1. doi request reprint Usefulness of taping in lower limb osteoarthritis. French clinical practice guidelines
    Pascal Richette
    Rheumatology Federation, Viggo Petersen Center, AP HP, Paris VII University, Lariboisière Teaching Hospital, Paris, France
    Joint Bone Spine 75:475-8. 2008
  2. doi request reprint Musculoskeletal complications of hereditary hemochromatosis: a case-control study
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris APHP, Hopital Lariboisiere, Federation de rhumatologie, Paris, France
    J Rheumatol 37:2145-50. 2010
  3. doi request reprint Colchicine for the treatment of gout
    Pascal Richette
    Federation de rhumatologie, Hopital Lariboisiere, Paris, France
    Expert Opin Pharmacother 11:2933-8. 2010
  4. doi request reprint Serum uric acid and metabolic risk
    P Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, Paris, France
    Curr Med Res Opin 29:9-15. 2013
  5. doi request reprint Psoriasis and phenotype of patients with early inflammatory back pain
    Pascal Richette
    Correspondence to Pr Pascal Richett, Federation de rhumatologie, Hopital Lariboisiere, 2 rue Ambroise Pare, 75475 Paris Cedex 10, France
    Ann Rheum Dis 72:566-71. 2013
  6. doi request reprint Novel drug discovery strategies for gout
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, 75475 Paris Cedex 10, France
    Expert Opin Drug Discov 8:183-9. 2013
  7. doi request reprint Impact of treatments for osteoporosis on cartilage biomarkers in humans
    P Richette
    Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, Universite Paris Diderot, 75010, Paris, France
    Osteoporos Int 23:S877-80. 2012
  8. doi request reprint [Gout: an overview of available urate lowering therapies]
    P Richette
    Federation de rhumatologie, Universite Paris Diderot, Sorbonne Paris Cité, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, Paris, France
    Ann Pharm Fr 70:133-8. 2012
  9. doi request reprint [Pharmacological therapies for osteoarthritis]
    Pascal Richette
    Hopital Lariboisiere, Paris, France
    Therapie 66:383-90. 2011
  10. pmc Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
    Xavier Chevalier
    Department of Rheumatology, University of Paris XII, Henri Mondor Hospital, Bd de Lattre de Tassigny, Creteil 94010, France
    Arthritis Res Ther 13:124. 2011

Collaborators

Detail Information

Publications44

  1. doi request reprint Usefulness of taping in lower limb osteoarthritis. French clinical practice guidelines
    Pascal Richette
    Rheumatology Federation, Viggo Petersen Center, AP HP, Paris VII University, Lariboisière Teaching Hospital, Paris, France
    Joint Bone Spine 75:475-8. 2008
    ..To develop clinical practice guidelines about the use of taping in the management of lower limb osteoarthritis...
  2. doi request reprint Musculoskeletal complications of hereditary hemochromatosis: a case-control study
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris APHP, Hopital Lariboisiere, Federation de rhumatologie, Paris, France
    J Rheumatol 37:2145-50. 2010
    ..We investigated whether HH is associated with increased prevalence of OA and OP and related factors...
  3. doi request reprint Colchicine for the treatment of gout
    Pascal Richette
    Federation de rhumatologie, Hopital Lariboisiere, Paris, France
    Expert Opin Pharmacother 11:2933-8. 2010
    ....
  4. doi request reprint Serum uric acid and metabolic risk
    P Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, Paris, France
    Curr Med Res Opin 29:9-15. 2013
    ..Lowering UA may be a novel treatment target for preventing diabetes and justify prospective clinical trials on the possible benefits of the measurement and lowering of serum UA on multiple chronic disease end points...
  5. doi request reprint Psoriasis and phenotype of patients with early inflammatory back pain
    Pascal Richette
    Correspondence to Pr Pascal Richett, Federation de rhumatologie, Hopital Lariboisiere, 2 rue Ambroise Pare, 75475 Paris Cedex 10, France
    Ann Rheum Dis 72:566-71. 2013
    ..Psoriasis is an important clinical feature in spondyloarthritis. However, the influence of psoriasis on the clinical, functional and imaging features of patients with inflammatory back pain (IBP) related to spondyloarthritis is not known...
  6. doi request reprint Novel drug discovery strategies for gout
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, 75475 Paris Cedex 10, France
    Expert Opin Drug Discov 8:183-9. 2013
    ..These difficult-to-treat patients currently represent about 3 - 5% of people with gout in Europe and the United States, which highlights the need for emerging treatments to effectively lower urate levels...
  7. doi request reprint Impact of treatments for osteoporosis on cartilage biomarkers in humans
    P Richette
    Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, Universite Paris Diderot, 75010, Paris, France
    Osteoporos Int 23:S877-80. 2012
    ..These data, which should be cautiously interpreted, suggest that these drugs might favorably affect cartilage homeostasis...
  8. doi request reprint [Gout: an overview of available urate lowering therapies]
    P Richette
    Federation de rhumatologie, Universite Paris Diderot, Sorbonne Paris Cité, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, Paris, France
    Ann Pharm Fr 70:133-8. 2012
    ..Another powerful hypo-uricemic drug is the PEG-uricase (pegloticase). Pegloticase is a uric acid-specific PEGylated recombinant mammalian uricase recently approved by the FDA for treatment of patients with refractory chronic gout...
  9. doi request reprint [Pharmacological therapies for osteoarthritis]
    Pascal Richette
    Hopital Lariboisiere, Paris, France
    Therapie 66:383-90. 2011
    ..Intra-articular injections of glucocorticoids are indicated for flare of knee pain, especially if accompanied by effusion...
  10. pmc Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
    Xavier Chevalier
    Department of Rheumatology, University of Paris XII, Henri Mondor Hospital, Bd de Lattre de Tassigny, Creteil 94010, France
    Arthritis Res Ther 13:124. 2011
    ..Although these data may suggest cessation of IL-1 therapy in osteoarthritis, other methods such as limited intraarticular anti-IL-1 delivery should still be considered...
  11. ncbi request reprint [Management of osteoarthritis: oral therapies]
    Pascal Richette
    Federation de rhumatologie, Hopital Lariboisiere, 75475 Paris
    Rev Prat 62:654-60. 2012
    ..Symptomatic slow acting drugs (avocado soybean unsaponifiable, chondroitin sulphate, diacerein, glucosamine sulphate) have mild symptomatic effects and may reduce the consumption of NSAID...
  12. doi request reprint Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, Paris, France
    Rheumatology (Oxford) 49:760-6. 2010
    ..To determine the effects of iron depletion on serum levels of joint biomarkers and on joint symptoms in patients with hereditary haemochromatosis (HH)...
  13. ncbi request reprint Bone mineral density in patients with rapidly destructive or common hip osteoarthritis
    P Richette
    Federation de rhumatologie, Hopital Lariboisiere, Hopital Fernand Widal, UFR médicale, Assistance Publique Hopitaux de Paris, Universite Paris 7, 75475 Paris Cedex 10, France
    Clin Exp Rheumatol 27:337-9. 2009
    ..Recent findings that subchondral insufficiency fracture in the femoral head may precede rapid chondrolysis suggest a role for systemic low bone mass in the genesis of rapidly destructive hip osteoarthritis (RDHOA)...
  14. doi request reprint [New therapeutic options for gout]
    Pascal Richette
    Universite Paris 7, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, UFR médicale, 2, rue Ambroise Pare, 75475 Paris Cedex 10, France
    Presse Med 40:844-9. 2011
    ..Biologic agents that inhibit IL-1 β such as canakinumab, rilonacept and anakinra have shown promising results for the treatment of gouty arthritis...
  15. doi request reprint Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, Paris Cedex, France
    Ann Rheum Dis 70:139-44. 2011
    ..To investigate the effect of massive weight loss on (1) knee pain and disability, (2) low-grade inflammation and metabolic status and (3) joint biomarkers in obese patients with knee osteoarthritis (OA)...
  16. pmc Comparison of general practitioners and rheumatologists' prescription patterns for patients with knee osteoarthritis
    Pascal Richette
    Univ Paris Diderot, Sorbonne Paris Cité, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, 75010, Paris, France
    BMC Musculoskelet Disord 12:72. 2011
    ..To compare the prescription modalities of general practitioners (GPs) and rheumatologists (RHs) for symptomatic knee osteoarthritis (OA) and to determine correlates with prescription of low-dose NSAIDs...
  17. doi request reprint [Calcium pyrophosphate deposition disease]
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, 2, rue Ambroise Pare, 75475 Paris Cedex 10, France
    Presse Med 40:856-64. 2011
    ..Oral NSAIDs can be used cautiously, in particular in the elderly. Prophylaxis against frequent recurrent acute CPP crystal arthritis can be achieved with low-dose oral colchicine...
  18. doi request reprint An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease
    Pascal Richette
    Federation de rhumatologie, Hopital Lariboisiere, Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Paris, France
    Rheumatology (Oxford) 48:711-5. 2009
    ..After the age of 55 years, hyperparathyroidism should be considered in all patients...
  19. ncbi request reprint [Chondrocalcinosis]
    Pascal Richette
    Universite Paris 7, UFR médicale, AP HP, Hopital Lariboisiere, Federation de rhumatologie, 75475 Paris Cedex 10
    Rev Prat 60:14-9. 2010
    ..There is good evidence that hereditary hemochromatosis, hyperparathyroidism and hypomagnesemia are metabolic disorders that predispose to secondary chondrocalcinosis...
  20. ncbi request reprint Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?
    Pascal Richette
    Department of Rhumatology, Hopital Lariboisiere, Paris, France
    J Rheumatol 34:438-9. 2007
  21. ncbi request reprint Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study
    Pascal Richette
    Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Paris, France
    Arthritis Rheum 57:1496-501. 2007
    ..To determine an association between magnesium (Mg) depletion and chondrocalcinosis, which has been reported but not investigated in a cross-sectional study...
  22. ncbi request reprint [Obesity and knee osteoarthritis]
    F Rannou
    Service de Rééducation, Groupe Hospitalier Cochin, APHP, Universite Paris Descartes, 75014 Paris, France
    Ann Readapt Med Phys 50:667-8. 2007
  23. ncbi request reprint Paradoxical adverse effects of anti-TNF-alpha treatment: onset or exacerbation of cutaneous disorders
    Manuelle Viguier
    , Inserm U697 and Department of Dermatology, , , Paris, France
    Expert Rev Clin Immunol 5:421-31. 2009
    ..Herein, we present a review of the different clinical patterns of these paradoxical cutaneous adverse disorders, and we propose recommendations for their management...
  24. doi request reprint Rheumatic manifestations of renal disease
    Thomas Bardin
    Federation de rhumatologie, Hopital Lariboisiere, Paris, France
    Curr Opin Rheumatol 21:55-61. 2009
    ....
  25. doi request reprint Nephrogenic systemic fibrosis
    Thomas Bardin
    Federation de rhumatologie, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, and Université Paris Diderot, Paris, France
    Curr Opin Rheumatol 22:54-8. 2010
    ....
  26. doi request reprint Impact of treatments for osteoporosis on osteoarthritis progression
    C Roux
    Assistance Publique Hopitaux de Paris, Hopital Cochin, Service de Rhumatologie, Universite Paris Descartes, 75014, Paris, France
    Osteoporos Int 23:S881-3. 2012
    ..Appropriate identification of patients at high risk of developing cartilage deterioration is a key issue for the analysis of impact of treatments for osteoporosis on osteoarthritis progression...
  27. ncbi request reprint Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis
    Pascal Richette
    Federation de rhumatologie, Hopital Lariboisiere, Paris, France
    J Rheumatol 31:2079-81. 2004
    ....
  28. doi request reprint Postoperative spondylodiscitis due to Kytococcus schroeteri in a diabetic woman
    H Jacquier
    Service de Bacteriologie Virologie, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Lariboisière Fernand Widal, Paris Cedex 10, France
    J Med Microbiol 59:127-9. 2010
    ..It has been described in prosthetic valve endocarditis but never as being involved in osteoarticular infections. We report here the first case of a spondylodiscitis due to K. schroeteri identified by 16S rRNA gene sequencing...
  29. ncbi request reprint Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994
    E Pertuiset
    Viggo Petersen Center, Lariboisière Teaching Hospital, Paris
    Medicine (Baltimore) 78:309-20. 1999
    ..There were 2 TB-related deaths. Our data suggest that SPwD may now be the most common pattern of spinal TB in foreign-born subjects in industrialized countries. The reasons for this remain to be elucidated...
  30. doi request reprint Efficacy of joint lavage in knee osteoarthritis: meta-analysis of randomized controlled studies
    Jerome Avouac
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, Paris Cedex, France
    Rheumatology (Oxford) 49:334-40. 2010
    ....
  31. ncbi request reprint [National ranking examination N16. What could fall at the exam?]
    Pascal Richette
    Federation de rhumatologie, Hopital Lariboisiere, Paris
    Rev Prat 56:183. 2006
  32. ncbi request reprint Structure-modifying agents for osteoarthritis: an update
    Pascal Richette
    Federation de rhumatologie, Lariboisière Teaching Hospital, 2 rue Ambroise Pare, 75010 Paris cedex 10, France
    Joint Bone Spine 71:18-23. 2004
    ..Although most of these agents have shown promising effects in vitro, none has been proven to produce clinically meaningful structure-modifying effects in humans with osteoarthritis...
  33. doi request reprint Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis
    Manuelle Viguier
    Unité INSERM U697, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, and Université Paris 7, Paris, France
    Arthritis Rheum 58:1796-802. 2008
    ..To investigate the nature of polyarthritis in patients with moderate to severe psoriasis undergoing treatment with efalizumab, a humanized anti-CD11a monoclonal antibody...
  34. ncbi request reprint A definite case of spondylodiscitis caused by Streptococcus equisimilis
    P Richette
    , Centre Viggo Petersen, Paris, France
    Clin Exp Rheumatol 19:587-8. 2001
    ..The patient did not have underlying disease and showed no obvious history of exposure to animals. We conclude that SE may be responsible for both septic arthritis and spondylodiscitis...
  35. ncbi request reprint Estrogens, cartilage, and osteoarthritis
    Pascal Richette
    Rheumatology Federation, Lariboisière Teaching Hospital, 2, rue Ambroise Pare, 75010 Paris, France
    Joint Bone Spine 70:257-62. 2003
    ..Finally, in vivo experiments in animals and in vitro studies have shed light on the mechanisms by which estrogens may influence chondrocyte metabolism...
  36. ncbi request reprint Hypomagnesemia and chondrocalcinosis in short bowel syndrome
    Pascal Richette
    Fédération de Rhumatologie and Service d hépatogastroenterologie et d assistance nutritive, Hopital Lariboisiere, Paris, France
    J Rheumatol 32:2434-6. 2005
    ..The underlying intestinal pathology was radiation enteritis in 2 patients and mesenteric arterial thrombosis in the third. Our observations strengthen the hypothesis of a role for magnesium in CPPD crystal deposition disease...
  37. doi request reprint Coccydynia related to calcium crystal deposition
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Federation de rhumatologie, Paris, France
    Spine (Phila Pa 1976) 33:E620-3. 2008
    ..Study of 4 cases of severe coccydynia revealing calcium deposits in the sacrococcygeal and intercoccygeal joints...
  38. ncbi request reprint Achondroplasia: from genotype to phenotype
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Hopital Lariboisiere, Centre Viggo Petersen, Federation de rhumatologie, 2 rue Ambroise Pare 75475 Paris cedex 10, France
    Joint Bone Spine 75:125-30. 2008
    ..The most common rheumatological complications of achondroplasia are medullar and radicular compressions due to spinal stenosis and deformities of the lower limbs. Current treatment and future therapies are discussed...
  39. ncbi request reprint A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis
    Pascal Richette
    Universite Paris 7, UFR médicale, Assistance Publique Hopitaux de Paris, Paris, France
    J Rheumatol 35:1650-4. 2008
    ....
  40. ncbi request reprint Splint for base-of-thumb osteoarthritis: a randomized trial
    Francois Rannou
    Assistance Publique Hopitaux de Paris, Hopital Cochin, Paris, France
    Ann Intern Med 150:661-9. 2009
    ..Some guidelines recommend splinting for base-of-thumb osteoarthritis, despite lack of evidence of efficacy...
  41. ncbi request reprint [Arthrosis]
    Pascal Richette
    Federation de rhumatologie, Hopital Lariboisiere, 75010 Paris
    Rev Prat 55:1933-42. 2005
  42. ncbi request reprint The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease
    Patrick Netter
    Laboratoire de Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS UHP, Faculte de Medecine, 54505 Vandoeuvre les Nancy, France
    Joint Bone Spine 71:365-8. 2004
    ..Recent studies show that growth factors and cytokines can modify the expression of the normal ANKH protein. These results suggest a role for ANKH in sporadic CPPD disease and in CPPD associated with degenerative disease...
  43. doi request reprint Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al
    Thi Huyen Tran Doan
    Arthritis Rheum 58:2210-1. 2008
  44. ncbi request reprint Correlation between serum and synovial fluid estrogen concentrations: comment on the article by Sowers et al
    Pascal Richette
    Arthritis Rheum 56:698; author reply 698-99. 2007